HIGHFDA DEVICE

Medtronic MiniMed 620G Insulin Pump Recall Impacts 799 Units Worldwide (2026)

Medtronic MiniMed recalled 799 infusion pumps worldwide, including in the United States. The devices in the Paradigm, 600, and BLE 700 series can deliver too much or too little insulin when their height relative to the infusion site changes due to gravity. Stop using the pump immediately and contact Medtronic MiniMed for instructions on replacement or refund.

Official notice
Medtronic MiniMedHealth & Personal CareMedical DevicesMiniMed 620G Insulin PumpParadigm series600 series

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DEVICE
Recall date
February 13, 2026
Status
ACTIVE
Severity
9/10

Quick Facts at a Glance

Recall Date
February 13, 2026
Hazard Level
HIGH
Brand
Medtronic MiniMed
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Medical Devices; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
Medtronic MiniMed
Product type
Insulin Pump
Model numbers
MiniMed 620G Insulin Pump, Paradigm series, 600 series, BLE 700 series
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    February 13, 2026

  2. Reported by FDA DEVICE

    April 8, 2026

  3. RecallRadar source check

    April 15, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death.

What You Should Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Medtronic MiniMed, Inc. or your healthcare provider for instructions. Notification method: Letter

About This Product

Medtronic MiniMed insulin pumps automate or assist insulin delivery for diabetes management. The 620G is part of older Paradigm/600 BLE lines and may connect with continuous glucose monitoring systems.

Why This Is Dangerous

The device's height relative to the infusion site affects hydrostatic and hydrodynamic pressures, causing potential insulin over-delivery or under-delivery.

Industry Context

This recall is not presented as part of a broader industry pattern in the provided data.

Real-World Impact

Patients may experience severe hypo- or hyperglycemia, requiring urgent medical care. The recall affects 799 units across a wide distribution network worldwide.

Practical Guidance

How to identify if yours is affected

  1. Check model numbers on device label and user manual
  2. Look up UDI-DI on packaging or device label
  3. Review recall notices for affected series (Paradigm, 600, BLE 700)
  4. Record date codes and serial numbers if available

Where to find product info

Device labels, user manuals, recall notices, FDA enforcement page

What timeline to expect

Refunds or replacements typically take 4-8 weeks after submission

If the manufacturer is unresponsive

  • Escalate to FDA recall complaint channels
  • Keep a detailed log of contacts
  • Seek legal advice if delays are prolonged

How to prevent similar issues

  • Register for recall alerts from Medtronic and FDA
  • Verify device status before use or replacement
  • Ask healthcare providers about newer pump models with updated safety features
  • Monitor for recall updates on official sites

Documentation advice

Keep all recall notices, device serial numbers, photos of labels, receipts, and all correspondence with Medtronic.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

Model numbers and devices affected include MiniMed 620G insulin pump and related Paradigm, 600, and BLE 700 series pumps. Distribution is worldwide, including US states and many countries.

Reported Incidents

No injuries or incidents have been reported.

Key Facts

  • High hazard level

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
9/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Details

Model Numbers
MiniMed 620G Insulin Pump
Paradigm series
600 series
BLE 700 series
Affected States
ALL
Report Date
April 8, 2026
Recall Status
ACTIVE

Related Recalls